Navigation Links
Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
Date:12/16/2008

g L-DOS47 and Topical Interferon Alpha-2b, will be successfully developed and commercialized as drugs or at all; uncertainty whether clinical trials will proceed as planned or at all, and the risk that clinical trial results may be negative; product liability, insurance and intellectual property risks; research and development risks; the need for further regulatory approvals, which may not be obtained; the Company's dependence on its contract service providers, licensors, optionees and other collaborators for performance; upscaling and manufacturing risks; partnership / strategic alliance risks; the effect of competition; uncertainty of the size and existence of a market opportunity for Helix's products; changes in business strategy or plans; as well as a description of other risks and uncertainties affecting Helix and its business, as contained in news releases and filings with securities regulatory authorities, including its latest Annual Information Form at www.sedar.com, any of which could cause actual results to vary materially from current results or Helix's anticipated future results. Forward-looking statements and information are based on the beliefs, assumptions and expectations of Helix's management at the time they are made, and Helix does not assume any obligation to update any forward-looking statement or information should those beliefs, assumptions or expectations, or other circumstances change, except as required by law.


'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CSL Behrings Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance
2. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
3. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
4. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
5. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
7. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
8. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
9. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
10. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
11. Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... New York (PRWEB) September 01, 2014 ... room in a hospital for performing surgical operations. An ... as operating tables, surgical booms, operating room lights, imaging ... According to a report by Transparency Market Research, a ... is expected to reach USD 4.5 billion by 2019. ...
(Date:9/1/2014)... Dennis Thompson HealthDay Reporter ... Ebola drug previously given to two American aid workers successfully ... in laboratory tests, researchers report. The drug, ZMapp, prompted ... they didn,t get the medication until five days after infection. ... who were days or even hours away from death, said ...
(Date:9/1/2014)... Washington, D.C. (PRWEB) September 01, 2014 ... is pleased to announce that Dawn Bazarko, DNP, MPH, ... become Fellows of the American Academy of Nursing. They ... PhD, MBA, RN-BC, CCM, FACHE, whose induction we reported ... on October 18, 2014, during the 2014 American Academy ...
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ... status conference in September, where issues related to claims ... Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... on the Court’s website, the meeting is scheduled to ... This is the latest of several Tylenol conferences that ...
(Date:9/1/2014)... Denver, Colorado (PRWEB) August 31, 2014 ... Now, an online resource and community that gives members ... image editing resources. , This online resource aims to ... tattoo, as well as artists who are looking for ... , Learn more about Tattoo Me Now by visiting ...
Breaking Medicine News(10 mins):Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
... go online with electronic health recordsNASHVILLE, Tenn., Jan. ... today that they and Cogdell Memorial Hospital are ... HMS to supply a fully integrated financial and ... Texas hospital closer to electronic health records (EHR) ...
... ATLANTA, Jan. 7 The TV Teacher, LLC(TM) announces ... select,New York City schools: Queens, Bronx, and Staten Island. ... Alphabet Beats(TM) was co-created,by Susan Ellis, a mother struggling ... write the alphabet. After an unsuccessful two years ...
... Jan. 7 David B. Snow Jr., chairman and chief ... ), is scheduled to address the 27th Annual JPMorgan Healthcare ... at the Westin St. Francis Hotel, San Francisco, will begin ... executives scheduled to attend are Richard J. Rubino, chief financial ...
... Boston Scientific Corporation (NYSE: BSX ) ... Health Care Conference in San Francisco.Jim Tobin, Chief Executive ... 14th, beginning at approximately 12:00 p.m. E.T. Following ... Financial Officer will join Mr. Tobin in a question ...
... Patent and Trademark Office (USPTO) has registered Guru ... relations strategy developed and honed by Tom Gable, ... The official USPTO language said the mark covered: ... of professional legal and accounting services, health care, ...
... Calif., Jan. 7 Agito Networks, Inc.(TM), ... mobility , today,announced that Technology Marketing Corporation,s ... named Agito Networks,RoamAnywhere(TM) Mobility Router(TM) as a ... , Agito Networks, ...
Cached Medicine News:Health News:Cogdell Memorial Hospital Partners with Healthcare Management Systems 2Health News:Cogdell Memorial Hospital Partners with Healthcare Management Systems 3Health News:New York Schools Receive Program for Children with Autism 2Health News:Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 2Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 4
(Date:8/29/2014)... Aug. 29, 2014 The Competitive Intelligence (CI) ... marketplace changes. CI leaders who adjust will succeed, and ... a new Best Practices, LLC study CI leaders from ... including: - Use secondary research whenever possible ... - Internal staff who are creative thinkers ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)... DIEGO , Aug. 29, 2014   ... emerging biopharmaceutical company, announced today that Santosh Vetticaden, ... be leaving the Company, for personal reasons, in ... Chief Medical Officer of Aires Pharmaceuticals, which Mast ... former responsibilities as the Company,s interim Chief Medical ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Calif., March 1, 2012  Bionovo, Inc. (OTC Link Platform: BNVI.PK), ... safe and effective treatments for women,s health and cancer, today ... President, will be presenting at the Cowen and Company 32nd ... 5, 2012.  The event will be held at the Boston ...
... England, March 1, 2012 Some of the ... cutting thousands of medical sales jobs in order to slash ... the industry. Biopharmaceutical giants AstraZeneca were the first ... be axed in 2012. The company has already seen an ...
Cached Medicine Technology:Job Cuts from Major Pharmaceutical Firms Results in Tougher Competition, Says Advance Recruitment 2
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Used to remove wrinkles from sections and for reorientating embedded tissue....
Prevents formation of microscopic ice crystals and sample distortion caused by slow freezing of hyperosmolar tissue samples in conventional cyrostats....
Liquichek Blood Gas Plus EGL Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2, electrolytes, glucose and lactate (lactic acid)....
Medicine Products: